Early videocapillaroscopic changes of the psoriatic skin after anti-tumour necrosis factor alpha treatment.
De Angelis
Rossella
R
Gasparini
Stefania
S
Bugatti
Leonardo
L
Filosa
Giorgio
G
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D002196:Capillaries; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003880:Dermatology; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D008297:Male; D008833:Microcirculation; D008853:Microscopy; D011565:Psoriasis / Q000188:drug therapy* / Q000503:physiopathology; D012867:Skin / Q000098:blood supply* / Q000187:drug effects; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab